Adalimumab 40 mg solution for injection — generic (India) (Humira-equivalent) Indications Adults - Moderate to severe active rheumatoid arthritis (as monotherapy or in combination with methotrexate) +380996042415 Drug delivery from abroad

Indications

Adults

- moderate to severe active rheumatoid arthritis (as monotherapy or in combination with methotrexate or other disease-modifying antirheumatic drugs). In combination with methotrexate, Humira reduces the rate of progression of joint damage (as measured by radiographic examination) and improves functional activity;

- active psoriatic arthritis (as monotherapy or in combination with methotrexate or other disease-modifying antirheumatic drugs);

- active ankylosing spondylitis;

- Crohn's disease (moderate or severe): in case of inadequate response to traditional therapy, as well as in case of intolerance or contraindications to traditional therapy; in case of ineffectiveness (or decreased effectiveness) or intolerance to infliximab;

- chronic plaque psoriasis (moderate to severe), when systemic therapy or phototherapy is indicated and when other systemic therapy options are not optimal;

- moderate to severe ulcerative colitis with an inadequate response to conventional therapy, including corticosteroids and/or 6-mercaptopurine or azathioprine, as well as with intolerance or contraindications to conventional therapy;

- axial spondyloarthritis without radiologically confirmed ankylosing spondylitis, but in the presence of objective signs of inflammation according to elevated C-reactive protein levels and/or MRI data, in the absence of an adequate response to treatment with NSAIDs or their intolerance;

- active suppurative hidradenitis of moderate or severe severity in the absence of an adequate response to standard systemic

therapy.